Director, Medical Communications

Join Immatics and shape the future of cancer immunotherapy; one patient at a time!  

Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. 

Why Join Us? 

• Innovative Environment: Help to pioneer advancements in cancer immunotherapy. 

• Collaborative Culture: Be part of a diverse team dedicated to your professional growth. 

• Global Impact: Contribute to therapies that make a lasting impact on patients globally. 

We are seeking a Director, Medical Communications to support our Commercial team. This role will lead global medical publications, congress strategy, and launch-critical scientific dissemination for Immatics’ priority programs, with a focus on anzu-cel market preparation and launch readiness. 

The Director is responsible for the high-quality, compliant delivery of manuscripts, abstracts, and scientific materials that translate emerging data into clear, decision-enabling narratives for internal and external stakeholders, informed by insights from advisory boards, publication reviews, and congress activities. 

Additionally, this role will own the Scientific Platform & Lexicon for anzu-cel and key programs, and drive a scalable data dissemination engine (in partnership with internal teams and agencies) to ensure consistent output, strategic data cadence, and measurable scientific impact and share of voice. 

FLSA Classification: Salary, Exempt  
Schedule: 8:00 AM – 5:00 PM; Monday to Friday  
Reports to: Senior Director, Medical Communications  
Location: Fully Remote 

What You’ll Do: 

As a Director, Medical Communications, you will play a key role in supporting our commercial operations:  

Publication Operations & Congress Execution 

• Lead the Global Publication Planning Team cadence (agendas, decisions, timelines, action tracking) and execute the rolling 12–24 month publication plan. 

• Drive end-to-end delivery of peer-reviewed and congress outputs (abstracts, manuscripts, posters, oral presentations), including author coordination and internal review cycles. 

• Define and maintain a global congress and publication disclosure calendar (12–24 months) that integrates analysis readiness, internal governance milestones, and external submission deadlines. 

• Own author/KOL strategy for priority publications (target journals/congress slots, authorship planning, competitive differentiation, and submission positioning) 

• Lead congress strategy and readiness for priority meetings (e.g., ASCO/ESMO/SITC/SMR/SGO), including narrative strategy, data packages, internal review governance, and post-congress dissemination planning 

Launch & Market Preparation Evidence Dissemination 

• Execute high-priority anzu-cel market preparation tactics, including manuscripts and congress packages that support clinical practice adoption, competitive differentiation, and launch readiness  

• Lead publication tactics involving complex analyses (secondary/tertiary/post hoc exploratory) and/or nontraditional datasets (e.g., compassionate use case studies, collaborative translational analyses with academia, and patient-authored manuscripts where appropriate) 

• Partner with cross-functional teams to translate evidence into medical education and scientific enablement needs (e.g., narrative modules, FAQs, scientific decks) that stand up to peer review and KOL scrutiny, maintain clear separation from promotional content, and adhere to compliance guardrails 

• Scientific Platform & Lexicon 

• Develop, maintain, and operationalize the Scientific Platform & Lexicon for anz